网站主页
化工产品目录
医药中间体
原料药中间体
(5R,8R,9R,10S,13S,14S)-13-甲基十四氢-3H-环戊二烯并[A]菲-3,17(2H)-二酮
(5R,8R,9R,10S,13S,14S)-13-甲基十二氢-1H-环戊二烯并[a]菲-3,17(2H,4H)-二酮
![(5R,8R,9R,10S,13S,14S)-13-甲基十二氢-1H-环戊二烯并[a]菲-3,17(2H,4H)-二酮](/SupplyImg/2024-01-16/202401161717533954472.png)
(5R,8R,9R,10S,13S,14S)-13-甲基十二氢-1H-环戊二烯并[a]菲-3,17(2H,4H)-二酮
(5R,8R,9R,10S,13S,14S)-13-Methyldodecahydro-1H-cyclopenta[a]phenanthrene-3,17(2H,4H)-dione
5696-51-5
5696-51-5
询价
1KG
起订
10KG
起订
上海 更新日期：2025-11-21
产品详情:
- 中文名称：
- (5R,8R,9R,10S,13S,14S)-13-甲基十二氢-1H-环戊二烯并[a]菲-3,17(2H,4H)-二酮
- 英文名称：
- (5R,8R,9R,10S,13S,14S)-13-Methyldodecahydro-1H-cyclopenta[a]phenanthrene-3,17(2H,4H)-dione
- CAS号：
- 5696-51-5
- 纯度规格：
- 99%+HPLC
- 产品类别：
- 黄金产品
公司简介
Founded by a group of veterans from the US biopharmaceutical industry in 2010, P&T is now a leading Shanghai-based CRO company providing drug discovery and development services worldwide
| 成立日期 | (12年) |
| 注册资本 | 200万人民币 |
| 员工人数 | 50-100人 |
| 年营业额 | ￥ 5000万-1亿 |
| 经营模式 | 工厂,定制 |
| 主营行业 | 医药中间体,原料药 |
(5R,8R,9R,10S,13S,14S)-13-甲基十二氢-1H-环戊二烯并[a]菲-3,17(2H,4H)-二酮相关厂家报价 更多
-
![3-[(8R,9S,10R,13S,14S)-10,13-二甲基-2,7,8,9,10,11,12,13,14,15-十氢-1H-环戊烯并[a]菲-17-基]吡啶](https://img.chemicalbook.com/SupplyImg1/2025-07-28/Large/202507281709293383800.png)
- 3-[(8R,9S,10R,13S,14S)-10,13-二甲基-2,7,8,9,10,11,12,13,14,15-十氢-1H-环戊烯并[a]菲-17-基]吡啶
- 郑州汇聚化工有限公司 VIP
- 2026-01-09
- 询价
-
![(8R,9S,13S,14S)-3-甲氧基-13-甲基-6,7,8,9,11,12,13,14,15,16-十氢-17H-环戊并[a]菲-17-酮](https://img.chemicalbook.com/SupplyImg1/2024-07-31/Large/202407311440397771131.png)
- (8R,9S,13S,14S)-3-甲氧基-13-甲基-6,7,8,9,11,12,13,14,15,16-十氢-17H-环戊并[a]菲-17-酮
- 河南威梯希化工科技有限公司 VIP
- 2025-12-25
- 询价
-
![(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-10,13-二甲基-2,16-二(哌啶-1-基)十六氢-1H-环戊烷[a]菲-3,17-二醇；](https://img.chemicalbook.com/SupplyImg1/2025-02-18/Large/202502181905492123637.png)
- (2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-10,13-二甲基-2,16-二(哌啶-1-基)十六氢-1H-环戊烷[a]菲-3,17-二醇；
- 上海切尔齐生物科技有限公司 VIP
- 2025-03-17
- 询价
-
- 5β-雌甾-3,17-二酮
- 天津那瑞医药科技有限公司 VIP
- 2026-01-04
- 询价
